应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06877 TE HEALTHCARE
已收盘 09-14 15:17:01
0.088
-0.002
-2.22%
最高
0.090
最低
0.087
成交量
34.40万
今开
0.090
昨收
0.090
日振幅
3.33%
总市值
1.79亿
流通市值
1.79亿
总股本
20.33亿
成交额
3.07万
换手率
0.02%
流通股本
20.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
TE HEALTHCARE 2026年中期营收7,450.60万港元,经调整净利润136.90万港元
公告速递 · 09-08
TE HEALTHCARE 2026年中期营收7,450.60万港元,经调整净利润136.90万港元
TE HEALTHCARE 8月股份变动月报表:股本维持不变
公告速递 · 09-01
TE HEALTHCARE 8月股份变动月报表:股本维持不变
TE HEALTHCARE:上半财年营收7450.60万港元
南方财经网 · 08-17
TE HEALTHCARE:上半财年营收7450.60万港元
TE HEALTHCARE(06877)公布2026年中期业绩:收入同比增64.9%至7,450万港元 首录140万港元归母净利
公告速递 · 08-17
TE HEALTHCARE(06877)公布2026年中期业绩:收入同比增64.9%至7,450万港元 首录140万港元归母净利
TE HEALTHCARE 7月无新增发行或股份变动
公告速递 · 08-03
TE HEALTHCARE 7月无新增发行或股份变动
TE HEALTHCARE(06877)将于8月17日审议2026年中期业绩及派息事宜
公告速递 · 07-31
TE HEALTHCARE(06877)将于8月17日审议2026年中期业绩及派息事宜
TE HEALTHCARE(06877.HK)预计上半年盈利约100万港元 同比扭亏为盈
中金财经 · 07-17
TE HEALTHCARE(06877.HK)预计上半年盈利约100万港元 同比扭亏为盈
TE HEALTHCARE(06877)预计中期扭亏为盈约100万元 核心保健业务收入增长抵销诉讼费用
公告速递 · 07-17
TE HEALTHCARE(06877)预计中期扭亏为盈约100万元 核心保健业务收入增长抵销诉讼费用
TE HEALTHCARE预期业绩亮眼,核心医疗业务及其他业务收入增长成主要驱动力
美股速递 · 07-17
TE HEALTHCARE预期业绩亮眼,核心医疗业务及其他业务收入增长成主要驱动力
TE HEALTHCARE(06877.HK)发盈喜 预计中期股东应占综合纯利约100万港元 同比扭亏为盈
智通财经 · 07-17
TE HEALTHCARE(06877.HK)发盈喜 预计中期股东应占综合纯利约100万港元 同比扭亏为盈
TE HEALTHCARE6月无新增发行或股份变动
公告速递 · 07-02
TE HEALTHCARE6月无新增发行或股份变动
TE HEALTHCARE(06877):王印卿将获委任为执行董事
智通财经 · 06-26
TE HEALTHCARE(06877):王印卿将获委任为执行董事
TE HEALTHCARE更新2026年5月股份变动月报表,股本维持稳定
公告速递 · 06-01
TE HEALTHCARE更新2026年5月股份变动月报表,股本维持稳定
TE HEALTHCARE 4月股份变动月报披露:股本维持不变
公告速递 · 05-04
TE HEALTHCARE 4月股份变动月报披露:股本维持不变
TE HEALTHCARE(06877)2025年度营收增长与经营调整并行,净亏损7,114,000港元凸显业务转型挑战
公告速递 · 04-14
TE HEALTHCARE(06877)2025年度营收增长与经营调整并行,净亏损7,114,000港元凸显业务转型挑战
TE Healthcare拟回购已发行股本最多10%股份
公告速递 · 04-14
TE Healthcare拟回购已发行股本最多10%股份
TE HEALTHCARE(06877)发布年度业绩 净亏损711.4万港元 同比盈转亏
智通财经 · 03-16
TE HEALTHCARE(06877)发布年度业绩 净亏损711.4万港元 同比盈转亏
CLSAPREMIUM03月11日获主力加仓22万元
市场透视 · 2025-03-11
CLSAPREMIUM03月11日获主力加仓22万元
CLSAPREMIUM03月10日主力净流入9万元 散户资金抛售
市场透视 · 2025-03-10
CLSAPREMIUM03月10日主力净流入9万元 散户资金抛售
CLSA PREMIUM盘中异动 临近午盘快速上涨5.07%报0.145港元
市场透视 · 2025-03-10
CLSA PREMIUM盘中异动 临近午盘快速上涨5.07%报0.145港元
加载更多
公司概况
公司名称:
TE HEALTHCARE
所属市场:
SEHK
上市日期:
--
主营业务:
卓著健康集团有限公司(原名:昆仑国际金融集团有限公司)是一家主要从事保健业务的投资控股公司。该公司通过两个分部运营业务。保健业务分部从事销售保健产品。未分配分部从事提供保证金交易及保健业务以外的服务及投资控股公司的营运。
发行价格:
--
{"stockData":{"symbol":"06877","market":"HK","secType":"STK","nameCN":"TE HEALTHCARE","latestPrice":0.088,"timestamp":1789370221065,"preClose":0.09,"halted":0,"volume":344000,"delay":0,"changeRate":-0.022222222222222244,"floatShares":2032999999,"shares":2032999999,"eps":-0.0035,"marketStatus":"已收盘","change":-0.002,"latestTime":"09-14 15:17:01","open":0.09,"high":0.09,"low":0.087,"amount":30671,"amplitude":0.033333,"askPrice":0.108,"askSize":20000,"bidPrice":0.088,"bidSize":80000,"shortable":0,"etf":0,"ttmEps":-0.001736,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"listingDate":1372780800000,"exchange":"SEHK","adjPreClose":0.09,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":3.659574,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06877","defaultTab":"news","newsList":[{"id":"1120311904","title":"TE HEALTHCARE 2026年中期营收7,450.60万港元,经调整净利润136.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120311904","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120311904?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:37","pubTimestamp":1788856621,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE发布的2026年中期财报显示,截至6月30日止六个月,公司实现营收约7,450.60万港元,同比增长65%。经调整净利润约为136.90万港元,同比扭亏为盈,增幅达162%。值得注意的是,报告期内其他经营开支为2,940.60万港元,同比增长44%,与市场推广、客户获取及业务基础设施投入增长有关;整体员工成本保持在139.30万港元左右,与去年同期基本持平。公司保健产品板块作为主要营收来源,报告期实现收入约7,086.50万港元,同比增长71%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"TE HEALTHCARE 2026年中期营收7,450.60万港元,经调整净利润136.90万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192853384","title":"TE HEALTHCARE 8月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1192853384","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192853384?lang=zh_cn&edition=full","pubTime":"2026-09-01 11:46","pubTimestamp":1788234415,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE于2026年9月1日发布截至2026年8月31日的股份变动月报表。公告显示,本月公司注册股本及已发行股本均保持稳定,未发生新增股份发行、购回、注销或库藏股变动。同时,公司确认其公众持股量符合香港联交所上市规则规定的最低要求。截至2026年8月末,公司股本总数维持不变。公司表示,将继续遵守香港联交所《上市规则》及其他相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660348581","title":"TE HEALTHCARE:上半财年营收7450.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660348581","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660348581?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:38","pubTimestamp":1786955880,"startTime":"0","endTime":"0","summary":"南财智讯8月17日电,TEHEALTHCARE(06877.HK)公告,截至2026年6月30日止六个月,公司实现营业收入7450.60万港元;毛利3080.00万港元;除税前溢利208.60万港元;基本及摊薄每股收益为0.07港仙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843204561.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843204561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TE","06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170955729","title":"TE HEALTHCARE(06877)公布2026年中期业绩:收入同比增64.9%至7,450万港元 首录140万港元归母净利","url":"https://stock-news.laohu8.com/highlight/detail?id=1170955729","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170955729?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:37","pubTimestamp":1786955823,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE8月17日披露截至2026年6月30日止六个月未经审核中期业绩。期内,公司收入总额7,450万港元,同比增加64.9%。受收入增长带动,集团2026年中期除税前录得溢利210万港元,而2025年同期为亏损160万港元;公司权益持有人应占溢利140万港元,较去年同期亏损220万港元实现扭亏为盈。成本端方面,保健产品销售成本由2,385.2万港元增至4,006.3万港元;转介开支及其他费用为155.3万港元。其他经营开支增至2,940.6万港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161197391","title":"TE HEALTHCARE 7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1161197391","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161197391?lang=zh_cn&edition=full","pubTime":"2026-08-03 14:46","pubTimestamp":1785739607,"startTime":"0","endTime":"0","summary":"2026年8月3日,Top Eminent Healthcare Group Limited披露截至2026年7月31日止的股份变动月报表。报告显示,公司注册股本与已发行股本在本月均无变化。报告期内,公司已发行股份总数维持2,033,290,000股,库藏股份数为0股,未见新增发行或购回注销记录。根据公告,TE HEALTHCARE确认截至7月31日已维持符合香港联交所的最低公众持股量规定。本月并无股份期权、权证、可换股票据或其他协议/安排的变动事项。公司股本结构及数量继续保持稳定。公告由公司秘书石永华签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188825485","title":"TE HEALTHCARE(06877)将于8月17日审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1188825485","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188825485?lang=zh_cn&edition=full","pubTime":"2026-07-31 16:36","pubTimestamp":1785487011,"startTime":"0","endTime":"0","summary":"根据TE HEALTHCARE(06877)7月31日发布的公告,公司董事会拟于2026年8月17日(星期一)召开会议,主要议程包括:第一,审议并批准集团截至2026年6月30日止六个月的中期业绩及其公布;第二,考虑宣派中期股息(如有)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409316","title":"TE HEALTHCARE(06877.HK)预计上半年盈利约100万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409316","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652409316?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:57","pubTimestamp":1784278623,"startTime":"0","endTime":"0","summary":"格隆汇7月17日丨TE HEALTHCARE(06877.HK)公布,截至2026年6月30日止六个月,集团预期将录得股东应占综合纯利约100万港元,对比2025年同期录得之股东应占综合亏损净额约220万港元,实现显著的扭亏为盈。\r\n\r\n 预期扭亏为盈主要归因于集团核心保健业务的收入稳步增长(受保健服务扩展及零售端(B2C)业务推动),从而抵销了集团期内产生的诉讼相关开支(包括向盛汇信息科技有限公司(“盛汇”)支付的判决款项及增加的法律费用)的不利影响。集团维持稳健的流动资金状况,为支持集团的持续营运提供了强大的财务缓冲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260717/32310585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4096","06877","BK1147","TE","CNRG","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139967726","title":"TE HEALTHCARE(06877)预计中期扭亏为盈约100万元 核心保健业务收入增长抵销诉讼费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1139967726","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139967726?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:42","pubTimestamp":1784277760,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE7月17日发布盈利预喜公告,公司经初步评估,预计截至2026年6月30日止六个月将录得股东应占综合纯利约100万元,而2025年同期则录得股东应占综合亏损净额约220万元,实现由亏转盈。TE HEALTHCARE强调,该费用金额未获公司同意且未经法院裁定;若双方无法达成协议,最终金额将由法院通过正式讼费评定程序确定。集团保健业务运营未受诉讼影响。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194969554","title":"TE HEALTHCARE预期业绩亮眼,核心医疗业务及其他业务收入增长成主要驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194969554","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194969554?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:38","pubTimestamp":1784277531,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE预计将取得出色的业绩表现,这主要得益于其核心医疗业务及其他业务板块的收入实现显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652405294","title":"TE HEALTHCARE(06877.HK)发盈喜 预计中期股东应占综合纯利约100万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2652405294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652405294?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:34","pubTimestamp":1784277270,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06877","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109527801","title":"TE HEALTHCARE6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1109527801","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109527801?lang=zh_cn&edition=full","pubTime":"2026-07-02 10:52","pubTimestamp":1782960721,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE于2026年7月2日发布6月股份变动月报表,报告期为2026年6月1日至2026年6月30日。公告显示,公司6月期间未发生任何新增发行、购回或注销股份等变动事项,股本结构保持稳定。公司于本报告期内未有新发行股份或回购活动,股本数量与上月底相比无变动。公司同日确认当前的公众持股量符合香港联交所关于最低公众持股量的相关规定。期权与激励计划方面,本月未见期权授出或行使的相关变动披露。公告由公司秘书石永华签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646553703","title":"TE HEALTHCARE(06877):王印卿将获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2646553703","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646553703?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:43","pubTimestamp":1782467036,"startTime":"0","endTime":"0","summary":"智通财经APP讯,TE HEALTHCARE(06877)发布公告,李冏先生因需要全心投入其他业务安排,将辞任公司非执行董事职务,自2026年6月30日起生效。王印卿女士将获委任为公司执行董事,自2026年7月1日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1147","BK4141","06877","TE","BK4096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117036689","title":"TE HEALTHCARE更新2026年5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1117036689","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117036689?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:46","pubTimestamp":1780282000,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE于2026年6月1日公布2026年5月股份变动月报表,显示公司截至2026年5月31日止的股份发行及库存情况未发生变化。公司法定注册股本保持在4,000,000,000股普通股,每股面值为0.01港元,对应注册股本总额40,000,000港元。期末已发行股本为2,033,290,000股,无库藏股份,与上月底数据一致。同时,公司确认符合香港联交所主板上市规则的最低公众持股量要求。本次月报由公司秘书石永华签署。公司表示,将继续严格遵守香港联交所相关上市规则及法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133198974","title":"TE HEALTHCARE 4月股份变动月报披露:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1133198974","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133198974?lang=zh_cn&edition=full","pubTime":"2026-05-04 11:52","pubTimestamp":1777866727,"startTime":"0","endTime":"0","summary":"Top Eminent Healthcare Group Limited于2026年5月4日发布截至2026年4月30日的股份变动月报表。报告显示,公司本月未新增发行或回购股份,股本结构保持稳定。已发行股份方面,截至2026年4月末,公司普通股已发行股份总数为2,033,290,000股,未持有任何库藏股份,与上月底数据相同,股本规模保持不变。公告并未披露任何股份期权或股权激励计划变动信息。本次公告由公司秘书石永华签署。公司指出,将持续遵守上市规则的合规要求,并在后续定期披露最新股本变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155717471","title":"TE HEALTHCARE(06877)2025年度营收增长与经营调整并行,净亏损7,114,000港元凸显业务转型挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=1155717471","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155717471?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:39","pubTimestamp":1776155955,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE于报告期内在多项业务板块推进转型与布局,同时经历了显著的财务及管理层变化。公司注册于开曼群岛,在香港设立总部及主要营业地点,并以股票代码06877在香港联合交易所上市。根据已披露资料,集团股权层面与中信证券国际有限公司存在股东关系,尚未见更多股权重组或特殊上市架构方面的信息。此后公司还于同年12月31日再次进行独立非执行董事的变动,并在2026年1月1日起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168874524","title":"TE Healthcare拟回购已发行股本最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1168874524","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168874524?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:36","pubTimestamp":1776155813,"startTime":"0","endTime":"0","summary":"TE HEALTHCARE公布,董事会已建议于股东周年大会上授予股份购回授权,规模最多占公司已发行股本的10%。该公司目前在香港联合交易所有限公司主板挂牌,最新已发行股本约为2,033,290,000股。若有关决议案获得批准,最多可回购约203,329,000股。董事会认为,此举有助于提升每股收益和股东回报,符合公司及股东的整体最佳利益。过去十二个月,TE HEALTHCARE股价最高曾达0.56港元,最低为0.125港元。董事会表示,若回购计划获通过,将在市场状况及资本需求允许下酌情执行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619445064","title":"TE HEALTHCARE(06877)发布年度业绩 净亏损711.4万港元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2619445064","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2619445064?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:41","pubTimestamp":1773661306,"startTime":"0","endTime":"0","summary":"智通财经APP讯,TE HEALTHCARE(06877)发布截至2025年12月31日止年度业绩,收入总额约1.07亿港元,同比增长3.93%;净亏损711.4万港元,同比盈转亏;每股基本亏损0.35港仙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TE","BK4096","BK1147","06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518233716","title":"CLSAPREMIUM03月11日获主力加仓22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518233716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518233716?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:16","pubTimestamp":1741681011,"startTime":"0","endTime":"0","summary":"03月11日,CLSAPREMIUM股价收平报0.15元,成交金额105万元,换手率0.35%,振幅5.33%,量比1.18。CLSAPREMIUM今日主力资金净流入22万元,上一交易日主力净流入9万元。该股近5个交易日上涨0.67%,主力资金累计净流入31万元;近20日主力资金累计净流入77万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170214abf60ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170214abf60ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06877","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518468712","title":"CLSAPREMIUM03月10日主力净流入9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518468712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518468712?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:16","pubTimestamp":1741594606,"startTime":"0","endTime":"0","summary":"03月10日, CLSAPREMIUM股价涨8.70%,报收0.15元,成交金额46万元,换手率0.16%,振幅7.97%,量比0.54。CLSAPREMIUM今日主力资金净流入9万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.25%,主力资金累计净流入9万元;近20日主力资金累计净流入55万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170458abf29592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170458abf29592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1147","06877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518263219","title":"CLSA PREMIUM盘中异动 临近午盘快速上涨5.07%报0.145港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518263219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518263219?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:38","pubTimestamp":1741577926,"startTime":"0","endTime":"0","summary":"2025年03月10日临近午盘11时38分,CLSA PREMIUM股票出现波动,股价大幅上涨5.07%。截至发稿,该股报0.145港元/股,成交量240.5万股,换手率0.12%,振幅4.35%。CLSA PREMIUM股票所在的药品分销行业中,整体跌幅为0.21%。其相关个股中,方舟健客、CLSA PREMIUM、阿里健康涨幅较大,振幅较大的相关个股有方舟健客、药师帮、阿里健康,振幅分别为55.88%、9.14%、6.69%。CLSA PREMIUM公司简介:CLSA Premium Ltd是一家主要从事提供杠杆式外汇、商品及指数交易服务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310113846a2694de1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310113846a2694de1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06877","BK1147"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kvblistco.com","stockEarnings":[{"period":"1week","weight":-0.0909},{"period":"1month","weight":-0.1},{"period":"3month","weight":-0.1743},{"period":"6month","weight":-0.4545},{"period":"1year","weight":-0.6018},{"period":"ytd","weight":-0.3878}],"compareEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0035},{"period":"6month","weight":-0.0259},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0322}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"卓著健康集团有限公司(原名:昆仑国际金融集团有限公司)是一家主要从事保健业务的投资控股公司。该公司通过两个分部运营业务。保健业务分部从事销售保健产品。未分配分部从事提供保证金交易及保健业务以外的服务及投资控股公司的营运。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.076156},{"month":2,"riseRate":0.375,"avgChangeRate":0.105042},{"month":3,"riseRate":0.25,"avgChangeRate":-0.055766},{"month":4,"riseRate":0.625,"avgChangeRate":0.133932},{"month":5,"riseRate":0.428571,"avgChangeRate":0.005205},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.049846},{"month":7,"riseRate":0.25,"avgChangeRate":-0.011102},{"month":8,"riseRate":0.375,"avgChangeRate":-0.009532},{"month":9,"riseRate":0.75,"avgChangeRate":-0.041974},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.064349},{"month":11,"riseRate":0.428571,"avgChangeRate":0.142247},{"month":12,"riseRate":0.285714,"avgChangeRate":0.029951}],"exchange":"SEHK","name":"TE HEALTHCARE","nameEN":"TE HEALTHCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TE HEALTHCARE(06877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TE HEALTHCARE(06877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TE HEALTHCARE,06877,TE HEALTHCARE股票,TE HEALTHCARE股票老虎,TE HEALTHCARE股票老虎国际,TE HEALTHCARE行情,TE HEALTHCARE股票行情,TE HEALTHCARE股价,TE HEALTHCARE股市,TE HEALTHCARE股票价格,TE HEALTHCARE股票交易,TE HEALTHCARE股票购买,TE HEALTHCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TE HEALTHCARE(06877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TE HEALTHCARE(06877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}